RXMD Progressive Care Inc

Progressive Care Inc. Garners International News Coverage in Leading Trade Publications for Its Efforts to Improve Adherence

Progressive Care Inc. Garners International News Coverage in Leading Trade Publications for Its Efforts to Improve Adherence

MIAMI, Dec. 04, 2018 (GLOBE NEWSWIRE) -- (), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication World Pharma Today stressing the importance of adherence and compliance in the space of medicine.

“We are honored to have Progressive Care’s efforts toward improving patient outcomes highlighted for the second time in such a noteworthy publication,” said S. Parikh Mars, CEO of Progressive Care Inc. “We are passionate about educating the public to be aware that pharmacists play a fundamental role in ensuring patient adherence and wellbeing.”

In a contributed article titled , published November 26, 2018, in World Pharma Today, Mars focuses on adherence and its significance for patients who are prescribed medications. Mars also dives deep into non-adherence and how it has caused a tremendous danger to our overall healthcare system.

In the piece, Mars writes: “Pharmacies influence patient behavior, improve adherence, and reduce costs across the spectrum. In order to do this, pharmacists must know their patients and use best practices to achieve results.”

Progressive Care has remained committed to taking steps to improve patient adherence, most recently the company has rolled out the Tele-PharmCo. 

The technology will facilitate two-way video conferencing between patients, healthcare professionals, and PharmCo’s team of pharmacists and pharmacy technicians through a secure video interface, allowing patients and their care providers to connect and interact with licensed pharmacists and pharmacy technicians in real-time and speak directly about any medical concerns.

In addition, PharmCo continues to offer its network the most current pharmacological information, a team of pharmacists and technicians highly trained in pain management and compounding and provides physician in-services, educational seminars, patient consultation, and customized medicinal pain management solutions.

The recent media coverage comes after the company’s efforts to provide its network with more healthcare informational resources through . Additional commentary from Progressive Care’s CEO about the company and industry as a whole can be found on the and .

For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:

Progressive Care Inc.



PharmCo, LLC



About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:

Kathleen Gonzales, CMW Media



Investor Relations Contact:

Armen Karapetyan, Progressive Care

Senior Advisor Business Development





EN
04/12/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progressive Care Inc

 PRESS RELEASE

Progressive Care Inc. Announces Record Second Quarter 2023 Results wit...

Progressive Care Inc. Announces Record Second Quarter 2023 Results with Revenues of $11.6 Million and Gross Margins of 31% MIAMI, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the second quarter ended June 30, 2023. The Company experienced record quarterly revenues of $11.6 million, a 16% growth from the second quarter ended June 30, 2022. “Over the past few months, our team was focused on ensuring that Progressive ...

 PRESS RELEASE

Progressive Care Inc. Announces First Quarter 2023 Financial Results a...

Progressive Care Inc. Announces First Quarter 2023 Financial Results and Record Quarterly Revenues of $11.4 Million MIAMI, FL, May 12, 2023 (GLOBE NEWSWIRE) -- via -- ‍Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the first quarter ended March 31, 2023. The Company experienced record quarterly revenues of $11.4 million, a 13% growth from the first quarter ended March 31, 2022. First Quarter 2023 Financial Highlights: Total pharmacy revenue increased...

 PRESS RELEASE

Progressive Care Inc. Announces Additional $1 Million Investment From ...

Progressive Care Inc. Announces Additional $1 Million Investment From NextPlat Corp. MIAMI, FL, May 11, 2023 (GLOBE NEWSWIRE) -- via – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced that it has successfully completed a transaction of $1 million investment from NextPlat Corp (NASDAQ: NXPL, NXPLW) (“NextPlat”), a global e-commerce provider. In connection with the $1 million investment, the Company sold to NextPlat 455,000 newly issued Units, with each Unit comprised of one share of th...

 PRESS RELEASE

Progressive Care Inc. Announces 2022 Annual Financial Results; $40.6 M...

Progressive Care Inc. Announces 2022 Annual Financial Results; $40.6 Million Total Revenue MIAMI, FL, April 03, 2023 (GLOBE NEWSWIRE) -- via – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the year ended December 31, 2022. Total revenue increased to $40.6 million, a 5% growth from the prior year. 2022 Annual Financial Highlights (at or for the year ended December 31, 2022, as compared to at or for the year ended December 31, 2021): Total pharmacy revenue increas...

 PRESS RELEASE

Progressive Care, Inc. Announces Reverse Stock Split and Will Trade Un...

Progressive Care, Inc. Announces Reverse Stock Split and Will Trade Under Temporary Symbol RXMDD Miami, FL, Dec. 30, 2022 (GLOBE NEWSWIRE) -- via  Progressive Care Inc. (OTCQB: RXMD and RXMDD): Progressive Care Inc. (OTCQB: RXMD and RXMDD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, announced today that its Board of Directors approved a 1-for-200 reverse stock split of its common stock shares and that the common stock shares will begin trading on a split-adjusted basis at the commencement of trading on December 30, 2022. The com...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch